Interstitial glucose monitoring in people with diabetes.

Abstract

Devices are now available that continuously measure the interstitial glucose of persons with diabetes. They have been shown to have a very positive impact on metabolic control of the disease, with blood sugar within acceptable ranges for a longer period and a significant reduction of low blood glucose, which makes for greater patient safety and comfort1-4. These monitors are included in the service portfolio of the National Health System in Spain, and are currently financed for patients with type 1 diabetes5, type 2 diabetes6 and other insulin-dependent patients (monogenetic diabetes, cystic fibrosis, pancreoprivic diabetes and hemochromatosis), as long as they are receiving intensive insulin therapy and require more than 6 finger pricks a day. Figure 2. Sensor of flash monitoring system